My Treatment Approach: Expanding Treatment Options for Relapsed/Refractory Follicular Lymphoma

Key opinion leaders in the field of follicular lymphoma management center discussion on patient cases to review the evolving treatment paradigm of relapsed/refractory disease.

EP. 1: Recent Treatment Guideline Updates in Follicular Lymphoma

July 14th 2023

Experts Sameh Gaballa, MD, and Matthew Lunning, DO, FACP, reflect on recent updates to the treatment guidelines for patients with follicular lymphoma.

EP. 2: Evolving Treatment Landscape of Relapsed/Refractory Follicular Lymphoma

July 14th 2023

A broad view of the current treatment paradigm for relapsed/refractory follicular lymphoma and how the field has been evolving.

EP. 3: Patient Scenario 1: An 83 -Year-Old With Relapsed/Refractory FL

September 1st 2023

Centering discussion on a patient scenario of relapsed/refractory follicular lymphoma, key opinion leaders consider how they would select best available therapy in this setting.

EP. 4: Role of BTK Inhibitors in Relapsed/Refractory Follicular Lymphoma

September 1st 2023

A brief review of BTK inhibitor therapy and its potential role within the relapsed/refractory follicular lymphoma treatment landscape.

EP. 5: First-Line Treatment Options for Patients With Follicular Lymphoma

September 8th 2023

Sameh Gaballa, MD, and Matthew Lunning, DO, FACP, review the frontline treatment armamentarium available to patients with follicular lymphoma.

EP. 6: Follicular Lymphoma: Patient Monitoring and Maintenance Therapy

September 8th 2023

Before closing out their discussion on first-line management of follicular lymphoma, experts consider the importance of patient monitoring and discuss the diminished role of maintenance therapy.

EP. 7: Relapsed/Refractory Follicular Lymphoma Treatment Armamentarium

September 15th 2023

Switching focus back to relapsed/refractory follicular lymphoma, Sameh Gaballa, MD, and Matthew Lunning, DO, FACP, consider the list of available treatment options in this setting.

EP. 8: Relapsed/Refractory Follicular Lymphoma: EZH2- and PIK3-Targeted Therapies

September 15th 2023

A brief discussion on the respective roles of EZH2- and PI3K-targeted therapies in patients with relapsed/refractory follicular lymphoma.

EP. 9: Patient Scenario 2: A 53-Year-Old Man With Relapsed/Refractory FL

September 22nd 2023

Centering discussion on a second patient scenario of follicular lymphoma, key opinion leaders consider best therapy for patients with early or aggressive relapse.

EP. 10: Relapsed/Refractory Follicular Lymphoma: Future Directions in Care

September 22nd 2023

Key opinion leaders Sameh Gaballa, MD, and Matthew Lunning, DO, FACP, consider the evolving treatment landscape of follicular lymphoma and look toward future evolutions in the field.